FDA Issues. Immediately upon receipt, but in no event later than one business day after receipt thereof, PPD shall provide CLIENT with a copy of any correspondence or notice it receives from the FDA relating to products or services covered by this Agreement. Further, PPD agrees to cooperate with CLIENT, if requested, in corresponding with the FDA or in filing any documents with respect to the products covered by this Agreement, as CLIENT deems necessary or desirable. Such services will be charged as stated on Attachment A.
Appears in 2 contracts
Sources: Product Safety/Pharmacovigilance Services Agreement (Reliant Pharmaceuticals, Inc.), Product Safety/Pharmacovigilance Services Agreement (Reliant Pharmaceuticals, Inc.)